Skip to content
Search

Latest Stories

Erectile Dysfunction Treatment: Eroxon STIMgel Now on NHS Prescriptions

Erectile Dysfunction Treatment: Eroxon STIMgel Now on NHS Prescriptions

Studies report more than a quarter of new Erectile Dysfunction cases are now diagnosed in men under 40

The UK based Pharma giant Futura Medical Plc’s lead product, Eroxon, a topical Stim-gel is now available on NHS prescription in England and Wales for the treatment of Erectile Dysfunction (ED).


The Muti-Drug Resistant (MDR) approved alternative to PDE5i, Eroxon is available as an over-the counter off shelf at retailers like Boots and Superdrug; and is available on NHS prescription in England and Wales as a CE-marked medical device.

Erectile dysfunction (ED), also known as impotence, is the inability to get and maintain an erection, typically concerning men over the age of 40 due to both, psychological and physical causes such as anxiety, depression, diabetes, and obesity.

According to UK Conformity Assessed (UKCA), the approval of the medication is based on evidence from 2 Phase three clinical studies, which showed that 60 per cent of patients taking Eroxon achieved Minimal Clinically Important Differences (MCID) at 12 weeks.

The multi-centre double-blind trials included more than 300 patients aged 18 years to 70 years from across nine EU nations who suffered mild to moderate levels of ED and standard treatment, or other treatments did not work well enough or could not be used.

Dr Catherine Hood, specialist in sexual medicine and psychosexual therapist and a member of the Eroxon ED Information Panel (EEDIP) assured that the ED STIMgel has also been clinically backed and investigated for improvement in erectile function compared with baseline.

How it works

The fast-action gel stimulates pressure and temperature-sensitive free-nerve endings in the glans penis to increase blood flow to achieve an erection. As the gel evaporates, it activates a rapid cooling sensation followed by gradual warming, giving results in 10 mins.

Like the PDE5i’s before it, Eroxon achieves an erection by increasing blood flow to the penis. But, unlike the system-wide action of the traditional oral therapies, the STIMgel achieves this vasodilation via a novel evaporative and cooling action.

Symptoms of Erectile Dysfunction to watch out for

The main symptom of sexual dysfunction is the inability to get and maintain an erection for satisfactory intercourse.

ED should not be confused with ejaculation problems such as premature ejaculation, which is a condition where the process of arousal, orgasm and ejaculation occurs very rapidly.

More For You

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less
Independent economic analysis will not be published before contract announcement, says NHSE

Pharmacy minister Stephen Kinnock

Independent economic analysis will not be published before contract announcement, says NHSE


The independent economic analysis of pharmacy finances will not be published before a new funding contract has been announced despite calls for the immediate release of the review.

Keep ReadingShow less
Beware of wage theft: PDA warns locums

Booking terms should clearly outline not only the dates of work, shift times, and rate of pay but also the required notice period

Getty Images

PDA warns locum pharmacists of ‘wage theft’ risk

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to check booking terms carefully before accepting shifts, warning of the risk of ‘wage theft’ and delayed payments.

According to the union, locum members have reported being owed significant unpaid fees for services provided, with some pharmacists claiming debts exceeding £20,000."

Keep ReadingShow less
UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less